AOS vs ONCO · P/E 19, rev $1.00B vs P/E 0.0, rev $815.4K
Smith AO Corporation (AOS) versus Onconetix Inc (ONCO) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Not investment advice. Open the AOS and ONCO stock pages for the full models.
Not investment advice.